Posaconazole-induced topiramate toxicity.
Marriott
Deborah
D
Levy
Russell
R
Doyle
Tom
T
Ray
John
J
D000855:Anorexia / Q000139:chemically induced; D000927:Anticonvulsants / Q000009:adverse effects* / Q000097:blood; D000935:Antifungal Agents / Q000009:adverse effects*; D051544:Cytochrome P-450 CYP3A; D065692:Cytochrome P-450 CYP3A Inhibitors; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced; D004347:Drug Interactions; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D053608:Stupor / Q000139:chemically induced; D000077236:Topiramate; D014230:Triazoles / Q000009:adverse effects*
D000927:Anticonvulsants; D000935:Antifungal Agents; D065692:Cytochrome P-450 CYP3A Inhibitors; D014230:Triazoles; D000077236:Topiramate; D005632:Fructose; C101425:posaconazole; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human